Derek Archila
Stock Analyst at Wells Fargo
(4.25)
# 482
Out of 5,182 analysts
232
Total ratings
51.57%
Success rate
14.25%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Equal-Weight | $29 → $20 | $13.90 | +43.88% | 4 | Mar 31, 2026 | |
| ALXO ALX Oncology Holdings | Initiates: Overweight | $5 | $1.96 | +155.10% | 1 | Mar 19, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintains: Overweight | $30 → $29 | $16.93 | +71.29% | 10 | Mar 18, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Overweight | $136 → $143 | $86.96 | +64.44% | 9 | Mar 12, 2026 | |
| SEPN Septerna | Maintains: Overweight | $28 → $48 | $24.78 | +93.70% | 6 | Mar 3, 2026 | |
| IRON Disc Medicine | Maintains: Overweight | $78 → $79 | $65.82 | +20.02% | 3 | Mar 2, 2026 | |
| ARGX argenx SE | Maintains: Overweight | $1,317 → $1,247 | $748.25 | +66.66% | 16 | Feb 27, 2026 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $114 → $110 | $52.25 | +110.53% | 4 | Feb 27, 2026 | |
| BBIO BridgeBio Pharma | Maintains: Overweight | $88 → $98 | $72.28 | +35.58% | 3 | Feb 13, 2026 | |
| INCY Incyte | Maintains: Equal-Weight | $107 → $101 | $94.86 | +6.47% | 13 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $29 | $15.79 | +83.66% | 8 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $322 → $330 | $226.69 | +45.57% | 16 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $26 | $40.63 | -36.01% | 14 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $479 → $376 | $330.34 | +13.82% | 2 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $39 | $21.94 | +77.76% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $33 | $8.98 | +267.48% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $69 → $116 | $85.27 | +36.04% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $25 | $8.91 | +180.58% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $27 | $5.80 | +365.52% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $11.22 | +33.69% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $81 | $62.43 | +29.75% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $30 | $43.98 | -31.79% | 4 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $7.40 | -32.43% | 12 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $10 | $2.84 | +252.11% | 6 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $1 | $0.82 | +21.36% | 3 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $44 → $38 | $31.37 | +21.13% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $40 → $30 | $23.95 | +25.26% | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $3.01 | -33.55% | 11 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $2.69 | +85.87% | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $15 | $5.64 | +165.96% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $14 | $25.84 | -45.82% | 5 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $45 | $24.89 | +80.80% | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $37 → $20 | $2.55 | +684.31% | 7 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.67 | +217.46% | 1 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $298 → $193 | $29.40 | +556.46% | 1 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $61 → $41 | $88.50 | -53.67% | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $480 → $160 | $14.64 | +992.90% | 3 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $180 → $60 | $20.36 | +194.70% | 3 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $29 | $6.97 | +316.07% | 4 | Dec 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $50 | $0.81 | +6,069.03% | 2 | Jun 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $51 | $18.61 | +174.05% | 1 | Nov 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $88 | $10.59 | +730.97% | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $22.27 | - | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $29.82 | - | 2 | Aug 3, 2017 |
Viridian Therapeutics
Mar 31, 2026
Maintains: Equal-Weight
Price Target: $29 → $20
Current: $13.90
Upside: +43.88%
ALX Oncology Holdings
Mar 19, 2026
Initiates: Overweight
Price Target: $5
Current: $1.96
Upside: +155.10%
Monte Rosa Therapeutics
Mar 18, 2026
Maintains: Overweight
Price Target: $30 → $29
Current: $16.93
Upside: +71.29%
Rhythm Pharmaceuticals
Mar 12, 2026
Maintains: Overweight
Price Target: $136 → $143
Current: $86.96
Upside: +64.44%
Septerna
Mar 3, 2026
Maintains: Overweight
Price Target: $28 → $48
Current: $24.78
Upside: +93.70%
Disc Medicine
Mar 2, 2026
Maintains: Overweight
Price Target: $78 → $79
Current: $65.82
Upside: +20.02%
argenx SE
Feb 27, 2026
Maintains: Overweight
Price Target: $1,317 → $1,247
Current: $748.25
Upside: +66.66%
Soleno Therapeutics
Feb 27, 2026
Maintains: Overweight
Price Target: $114 → $110
Current: $52.25
Upside: +110.53%
BridgeBio Pharma
Feb 13, 2026
Maintains: Overweight
Price Target: $88 → $98
Current: $72.28
Upside: +35.58%
Incyte
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $107 → $101
Current: $94.86
Upside: +6.47%
Jan 29, 2026
Maintains: Overweight
Price Target: $30 → $29
Current: $15.79
Upside: +83.66%
Jan 20, 2026
Maintains: Overweight
Price Target: $322 → $330
Current: $226.69
Upside: +45.57%
Jan 20, 2026
Maintains: Overweight
Price Target: $29 → $26
Current: $40.63
Upside: -36.01%
Jan 20, 2026
Maintains: Equal-Weight
Price Target: $479 → $376
Current: $330.34
Upside: +13.82%
Jan 6, 2026
Maintains: Overweight
Price Target: $17 → $39
Current: $21.94
Upside: +77.76%
Dec 16, 2025
Maintains: Overweight
Price Target: $31 → $33
Current: $8.98
Upside: +267.48%
Dec 9, 2025
Maintains: Overweight
Price Target: $69 → $116
Current: $85.27
Upside: +36.04%
Dec 8, 2025
Maintains: Overweight
Price Target: $19 → $25
Current: $8.91
Upside: +180.58%
Nov 19, 2025
Maintains: Overweight
Price Target: $14 → $27
Current: $5.80
Upside: +365.52%
Nov 6, 2025
Maintains: Overweight
Price Target: $16 → $15
Current: $11.22
Upside: +33.69%
Nov 5, 2025
Maintains: Overweight
Price Target: $51 → $81
Current: $62.43
Upside: +29.75%
Oct 21, 2025
Maintains: Equal-Weight
Price Target: $36 → $30
Current: $43.98
Upside: -31.79%
Oct 17, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $7.40
Upside: -32.43%
Sep 23, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $2.84
Upside: +252.11%
Sep 16, 2025
Downgrades: Equal-Weight
Price Target: $25 → $1
Current: $0.82
Upside: +21.36%
Aug 20, 2025
Maintains: Overweight
Price Target: $44 → $38
Current: $31.37
Upside: +21.13%
Aug 12, 2025
Maintains: Equal-Weight
Price Target: $40 → $30
Current: $23.95
Upside: +25.26%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $3.01
Upside: -33.55%
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $2.69
Upside: +85.87%
Mar 12, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $5.64
Upside: +165.96%
Dec 19, 2024
Maintains: Equal-Weight
Price Target: $12 → $14
Current: $25.84
Upside: -45.82%
Dec 19, 2024
Maintains: Overweight
Price Target: $47 → $45
Current: $24.89
Upside: +80.80%
May 5, 2021
Downgrades: Hold
Price Target: $37 → $20
Current: $2.55
Upside: +684.31%
Aug 4, 2020
Initiates: Buy
Price Target: $18
Current: $5.67
Upside: +217.46%
Jul 10, 2020
Downgrades: Hold
Price Target: $298 → $193
Current: $29.40
Upside: +556.46%
Apr 15, 2020
Reiterates: Buy
Price Target: $61 → $41
Current: $88.50
Upside: -53.67%
Mar 31, 2020
Maintains: Hold
Price Target: $480 → $160
Current: $14.64
Upside: +992.90%
Mar 17, 2020
Downgrades: Hold
Price Target: $180 → $60
Current: $20.36
Upside: +194.70%
Dec 11, 2018
Downgrades: Perform
Price Target: $29
Current: $6.97
Upside: +316.07%
Jun 22, 2018
Maintains: Outperform
Price Target: $34 → $50
Current: $0.81
Upside: +6,069.03%
Nov 15, 2017
Maintains: Outperform
Price Target: $32 → $51
Current: $18.61
Upside: +174.05%
Sep 7, 2017
Initiates: Outperform
Price Target: $88
Current: $10.59
Upside: +730.97%
Sep 7, 2017
Initiates: Market Perform
Price Target: n/a
Current: $22.27
Upside: -
Aug 3, 2017
Downgrades: Perform
Price Target: n/a
Current: $29.82
Upside: -